{"id":649483,"date":"2013-03-28T17:35:41","date_gmt":"2013-03-28T21:35:41","guid":{"rendered":"http:\/\/www.pehub.com\/?p=193749"},"modified":"2013-03-28T17:35:41","modified_gmt":"2013-03-28T21:35:41","slug":"in-shangpharmas-going-private-transaction-ropes-gray-represented-buyer-consortium","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/649483","title":{"rendered":"In ShangPharma’s Going-Private Transaction, Ropes & Gray Represented Buyer Consortium"},"content":{"rendered":"

Ropes & Gray<\/strong>, the global law firm, represented TPG Growth<\/strong> and Michael Xin Hui<\/strong> in their effort to take private ShangPharma<\/strong>, a China-based contract research organization. Hui is ShangPharma’s CEO. The deal closed on Wednesday.<\/p>\n

PRESS RELEASE:<\/strong><\/p>\n

Ropes & Gray represented the buyer group consortium of TPG Growth and ShangPharma\u2019s CEO, Michael Xin Hui, ShangPharma\u2019s going private transaction, which closed March 27. <\/p>\n

ShangPharma is a leading, China-based contract research organization. <\/p>\n

The transaction is just the second private equity sponsor-backed going-private transaction of a China-based, NYSE or NASDAQ listed company to sign and close since the beginning of 2012. <\/p>\n

The Ropes & Gray team advising the buyer group and TPG is led by Asia-based partners Scott Jalowayski and Paul Boltz.<\/p>\n

The post In ShangPharma’s Going-Private Transaction, Ropes & Gray Represented Buyer Consortium<\/a> appeared first on peHUB<\/a>.<\/p>\n

\n<\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a>\n<\/div>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Ropes & Gray, the global law firm, represented TPG Growth and Michael Xin Hui in their effort to take private ShangPharma, a China-based contract research organization. Hui is ShangPharma’s CEO. The deal closed on Wednesday. PRESS RELEASE: Ropes & Gray represented the buyer group consortium of TPG Growth and ShangPharma\u2019s CEO, Michael Xin Hui, ShangPharma\u2019s […]<\/p>\n","protected":false},"author":7567,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-649483","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/649483","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/7567"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=649483"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/649483\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=649483"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=649483"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=649483"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}